Skip to main content
. 2013 Sep 5;2:24. doi: 10.1186/2162-3619-2-24

Figure 1.

Figure 1

Summary of blood counts, molecular analyses and cytoreductive therapy in a patient with a CML with JAK2V617F clonal evolution under treatment with imatinib and dasatinib.